BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 9, 2026
See today's BioWorld
Home
» Collaboration key to maximizing drug value
To read the full story,
subscribe
or
sign in
.
Collaboration key to maximizing drug value
July 20, 2015
By
Brian Orelli
Every drug company wants to get the best price for its drugs, but that's easier said than done, especially in the current environment with payers pushing back at high drug prices and pitting companies against each other to compete on price.
BioWorld